JCM
IRON icon

JS Capital Management’s Disc Medicine IRON Stock Holding History

JS Capital Management’s Portfolio IRON Stock Details IRON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-15,815
Closed -$1.38M – 31
2021
Q4 		$1.38M Hold
15,815
– – 0.06% 37
2021
Q3 		$1.92M Hold
15,815
– – 0.11% 38
2021
Q2 		$3.07M Hold
15,815
– – 0.15% 35
2021
Q1 		$6.43M Buy
+15,815
New +$7.05M 0.33% 36

Other funds holding IRON

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
FCOMV
Foresite Capital Opportunity Management V Larkspur, California $33.3M AUM 47.04% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JS Capital Management's IRON Position: Q1 2022 in Review

JS Capital Management sold out of Disc Medicine (IRON) in Q1 2022, closing a stake of 15,815 shares — an estimated $1.38M sold.

JS Capital Management first reported a position in IRON in Q1 2021 and held it in 4 quarters. The position peaked at $6.43M in Q1 2021. 57 funds tracked by Wall St. Rank hold IRON as of Q1 2022.

  • JS Capital Management reported no remaining Disc Medicine position as of Q1 2022 after selling out during the quarter.
  • JS Capital Management sold 15,815 Disc Medicine shares in Q1 2022, an estimated $1.38M.
  • JS Capital Management first reported a position in Disc Medicine in Q1 2021 and held it in 4 quarters.
  • JS Capital Management's Disc Medicine position peaked at $6.43M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Disc Medicine as of Q1 2022.

Based on JS Capital Management's 13F filing for Q1 2022, filed 16 May 2022.